Skip to main content

Meggs Jason M.'s Form 4 filing

Syneos Health, Inc. (SYNH) · filed Jul 7, 2021

Accession no.
0001209191-21-045846
Filed
Jul 7, 2021
Trade date
Jul 6, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $59.4K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Meggs Jason M.CIK 0001660670Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 6, 2021Class A Common StockMOption exerciseAcquired+40$43.16+$1,726.460,741Direct
Jul 6, 2021Class A Common StockSSaleDisposed−40$90.00−$3,60060,701Direct
Jul 6, 2021Class A Common StockMOption exerciseAcquired+620$46.00+$28,52061,321Direct
Jul 6, 2021Class A Common StockSSaleDisposed−620$90.00−$55,80060,701Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 6, 2021Class A Common StockMOption exerciseDisposed−620$0.00$00Direct
Jul 6, 2021Class A Common StockMOption exerciseDisposed−40$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)